Cervical Cancer Screening in Pregnancy

Stonehocker, Jody

doi:10.1016/j.ogc.2013.03.005

Cited by 28 publications

(14 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In this context, it should be noted that the accuracy of the cytology examination does not vary with gestation [10]. Moreover, our results are in concordance with current literature [9,15] because rates of HSIL do not differ between pregnant and nonpregnant women, even when stratified by risk factors (age, time interval between examinations, and age at first sexual intercourse).…”

Section: Discussionsupporting

confidence: 91%

“…Pregnancy and childbirth have been suggested to influence the natural history of cervical cancer [9,10,15,16] and the prevalence of HPV infection [17], which suggests that pregnancy is not a risk factor for an abnormal cytology test result. In addition, Lee et al [9] found no difference in overall survival between pregnant and non-pregnant women with early stage carcinoma of the cervix.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, it has been suggested that women younger than 30 years should undergo screening exclusively by cytology examination [3,8]. Because cervical carcinoma is frequently diagnosed during pregnancy [8][9][10], it would be useful to determine whether the prevalence of precursor lesions is similar between pregnant women and their non-pregnant counterparts.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Results of screening for cervical cancer among pregnant and non‐pregnant women in Brazil

Xavier‐Júnior

Vale

Vieira

et al. 2015

Intl J Gynecology & Obste

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Results of screening for cervical cancer among pregnant and non‐pregnant women in Brazil

Xavier‐Júnior

Vale

Vieira

et al. 2015

Intl J Gynecology & Obste

View full text Add to dashboard Cite

show abstract

“…[5] The incidences of CIN and HPV infection in pregnant women are generally comparable to that of nonpregnant women. [1617] In Maiduguri, Northern Nigeria, the prevalence of 7.8% was obtained following review of Pap smear over 15-year period. [18]…”

Section: Discussionmentioning

confidence: 99%

The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital

2017

View full text Add to dashboard Cite

Background:In spite of knowledge of the causes and prevention of cervical cancer, screening programs for cervical cancer have not yet been fully implemented in most developing countries including Nigeria. Documented data on the prevalence of preinvasive cervical lesion in pregnancy are scarce in our environment.Objectives:To determine the prevalence, risk factors, and course of preinvasive cervical lesion in pregnant women attending an antenatal clinic in Ahmadu Bello University Teaching Hospital (ABUTH) Zaria, Northern NigeriaStudy Design:This was a cross-sectional longitudinal study.Setting:The study was conducted in an antenatal clinic of ABUTH Zaria.Materials and Methods:A prospective cross-sectional longitudinal analysis was carried out at an Antenatal Clinic of ABUTH Zaria, Nigeria. A total of 250 consecutive pregnant women who fulfilled the inclusion criteria and have given their consent were recruited into the study at the time of their first prenatal (booking clinic) visit for antenatal care. Data from the pregnant women were obtained using a pro forma to evaluate sociodemographic characteristics and risk factors for preinvasive disease. Conventional Papanicolaou smear was taken using the standard procedure. The cytopathologic findings of initial and postpartum Pap smear were documented in the pro forma. Prevalence, persistence, progression, and regression rates of preinvasive diseases were determined.Results:Out of the 250 pregnant women who had cervical cytology by Pap smear during the study, 15 had preinvasive cervical lesion, giving a prevalence rate of 6%; 13 (87%) were low-grade squamous intraepithelial lesion (LGSIL) while 2 (13%) were high-grade squamous intraepithelial lesion (HGSIL). Negative smears were seen in 158 women (63.2%). Inflammatory and other conditions of the cervix which are technically negative smears made up the remaining 30.8%. At postpartum follow-up of the 13 women with LGSIL, 2 (15.4%) became negative while persistence of the disease was observed in 9 (69.2%) of the cases. Two women with LGSIL were lost to follow-up. Of the two women with HGSIL, persistence of the disease was seen in one woman (50%) and regression of the disease was seen in the other woman. Risk factors that were found to be associated with preinvasive cervical lesion were age at coitarche <16 years, number of sexual partners since coitarche, and previous history of sexually transmitted infection and human immunodeficiency virus. Parity, smoking, and use of contraception were found not to be significant risk factors.Conclusion:Preinvasive lesion of the cervix is relatively common among antenatal clients in our center. Antenatal clients with HGSIL should have a repeat smear at the end of the puerperium before treatment. Routine Pap smear should be offered to all antenatal clients in our setting.

show abstract

“…Além disso, a realização de exames desnecessários pode aumentar os custos do sistema público de saúde. Entretanto, cabe lembrar que a gestação é uma oportunidade para realização do exame citopatológico em mulheres que nunca foram submetidas a este exame, nas que não estão em acompanhamento 16,17 , ou, ainda, para seguir o que preconizam o Ministério da Saúde e o INCA, que indicam a realização do exame citopatológico a cada três anos após dois resultados negativos com intervalo de um ano entre si 3,18 . Estudos apontam diferença tanto na prevalência de lesões precursoras como na chance de progressão para neoplasia do colo uterino quando consideramos como variável o estado gestacional.…”

Section: Discussionunclassified

Frequência de células escamosas atípicas de significado indeterminado (ASCUS) em mulheres grávidas e não grávidas

Düfloth¹,

Vieira²,

Júnior³

et al. 2015

Rev. Bras. Ginecol. Obstet.

View full text Add to dashboard Cite

Frequência de células escamosas atípicas de significado indeterminado (ASCUS) em mulheres grávidas e não grávidas Frequency of atypical squamous cells of undetermined significance (ASCUS) for pregnant and non-pregnant womenComparisons were made between pregnant and non-pregnant women, and the sample was stratified into three age groups (20-24, 25-29 and 30-34 years). The χ 2 test was used and the magnitude of association was determined by the by Odds Ratio (OR) with the 95% confidence interval (95%CI). RESULTS: A Total of 447,489 samples were excluded on the basis of the criteria adopted, for a total final sample of 37,137 pregnant women and 851,554 non-pregnant women. An ASCUS result was detected in 1.2% of cases, with a significant difference between pregnant and non-pregnant women in the age groups of 20-24 years (OR=0.85; 95%CI 0.75-0.97) and 25-29 years (OR=0.78; 95%CI 0.63-0.96). There was no difference in the group between 30-34 years (OR=0.76; 95%CI 0.57-1.03). CONCLUSIONS: This study suggested that non-pregnant women have a higher frequency of ASCUS, most evident in the age group of 20 to 29 years. The collection of cervical cancer screening should not be a compulsory part of the prenatal routine.

show abstract

Cervical Cancer Screening in Pregnancy

Cited by 28 publications

References 46 publications

Results of screening for cervical cancer among pregnant and non‐pregnant women in Brazil

Results of screening for cervical cancer among pregnant and non‐pregnant women in Brazil

The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital

Frequência de células escamosas atípicas de significado indeterminado (ASCUS) em mulheres grávidas e não grávidas

Contact Info

Product

Resources

About